Author:
Das Sudipta,St. Croix Claudette,Good Misty,Chen Jie,Zhao Jinming,Hu Sanmei,Ross Mark,Myerburg Michael M.,Pilewski Joseph M.,Williams John,Wenzel Sally E.,Kolls Jay K.,Ray Anuradha,Ray Prabir
Funder
National Institutes of Health
Reference78 articles.
1. Safety, tolerability, pharmacokinetics, and immunogenicity of motavizumab, a humanized, enhanced-potency monoclonal antibody for the prevention of respiratory syncytial virus infection in at-risk children;Abarca;Pediatr. Infect. Dis. J.,2009
2. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia;Aujla;Nat. Med.,2008
3. IL-22: a critical mediator in mucosal host defense;Aujla;J. Mol. Med. (Berl.),2009
4. MEK inhibition drives anti-viral defence in RV but not RSV challenged human airway epithelial cells through AKT/p70S6K/4E-BP1 signalling;Baturcam;Cell Commun. Signal.,2019
5. A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability;Beale;Cell Host Microbe,2014
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献